Name: Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis (Video) | JoVE Journal
Uploaded: 2018-08-07T15:00:00.000+00:00
Duration: 8 min 55 s
Description: Learn live-cell microscopy and NMR techniques to characterize MLKL-mediated plasma membrane rupture in necroptosis using mouse embryonic fibroblasts. These methods directly implicate MLKL as the executioner of cell death.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

1. Cloning and Cell Line Generation
<ol>
	<li>PCR amplify the NBB region, corresponding to amino acid residues 1-140 (NBB140), from human MLKL cDNA for in frame standard restriction enzyme-based cloning with the oligomerization domain 2x FK506 binding protein (2xFKBP or 2xFV) and Venus fluorescent protein into the Doxycycline (Dox)-inducible retroviral vector pRetroX-TRE3G to obtain NBB140-2xFV-Venus (Table 1, Figures 1A-B).</li>
	<li>Immortalize primary mlkl-/- or ripk3-/- mlkl-/-&#160;mouse embryonic fibroblasts (MEFs) obtained from the respective mice available in the Green laboratory by transient transfection with SV40-large antigen expressing plasmid. Select immortalized cells in ~1&#8211;2 weeks, and maintain in DMEM supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin and streptomycin, 1 mM sodium pyruvate, and nonessential amino acids at 37 &#176;C and 5% CO2 in standard tissue culture incubators.</li>
	<li>Transduce SV40-immortalized mlkl-/- MEFs with the reverse tetracycline controlled transactivator (rtTA)-containing retrovirus expressed from a plasmid containing the blasticidin resistance gene (our modified plasmid) and treat for 1 week with 5 &#956;g/mL blasticidin to select for cells stably expressing rtTA28.</li>
	<li>Transduce the rtTA-expressing MEFs with the Dox-inducible retroviral vector containing the chimeric MLKL (pRetroX-NBB140-2xFV-Venus-puro) and select using 4 &#956;g/mL puromycin for one week, 2 days after transduction.</li>
</ol>
2. Live-Cell Microscopy Imaging of MLKL-mediated Necroptosis
<ol>
	<li>Plate mlkl-/- MEFs expressing NBB140-2xFV-Venus at a density of 50,000 cells per well (1 mL/well) in 24 well plates, and incubate overnight (Figure 2A). Use live-cell staining for automated cell counting (see Table of Materials).</li>
	<li>Treat cells for 12 h with Dox (0.5 &#956;g/mL) to induce the expression of NBB140-2xFV-Venus.</li>
	<li>Induce necroptosis with 25 nM FKBP dimerizer (Dim) in addition to&#160;25 nM membrane-impermeable green fluorescent dye (see Table of Materials) in standard DMEM (see 1.2). Cells undergoing necroptosis accumulate the dye as their plasma membrane integrity is compromised by NBB140-mediated rupture. Perform assays in triplicate or quadruplicate.</li>
	<li>To monitor necroptosis using single- or dual-color imaging systems (see Table of Materials), place the vessels in the respective imaging unit housed in a mammalian tissue culture incubator.</li>
	<li>Open the software (see Table of Materials) and select the tab Schedule Upcoming Scans under the Tasks List. 
	NOTE: This protocol is for imaging using single-color systems, but a similar software is available for&#160;dual-color systems.</li>
	<li>Select the &#34;Tray, Vessel, Scan Types&#34;, and the &#34;Scan Pattern&#34; in the &#34;Physical Layout&#34; tab and &#34;Fast Fluorescence&#34; in the Properties tab.</li>
	<li>Add the &#34;Scan Time&#34; by clicking on the &#34;Timeline&#34; window and the total number of time points and frequency of acquisition (typically 1 acquisition every 0.5 h to 1 h for 6 h to 12 h, or every 5 min for fast-kinetics necroptosis) and start image acquisition by selecting &#34;Apply&#34; (red button).</li>
	<li>Quantify necroptosis using the image analysis software (see Table of Materials) by selecting from the &#34;Tasks Pane&#34;, &#34;Object Counting New Analysis with Fixed Segmentation Threshold above the background level&#34;, which can be determined by hovering the mouse cursor over background regions in several images used in the analysis.</li>
	<li>Examine fluorescent objects by selecting Previewing using current image and refine the Threshold levels as needed.</li>
	<li>Integrate green fluorescence counts by opening&#160;the &#34;Launch New Analysis&#34; tab, choose the &#34;Time Range&#34;, select the wells to be analyzed, enter the &#34;Analysis Job Name&#34;, and press &#34;OK&#34;.</li>
	<li>Access analyzed data from the &#34;Analysis Jobs&#34; tab by double-clicking on the respective job name and exporting from the Graph/Export window for additional analysis in external graphing software (see Table of Materials).</li>
	<li>Quantitate data as green fluorescence positive (+ve) counts/mm2 or normalize the counts by confluence and express the data as green fluorescence +ve counts/confluence.</li>
	<li>Optionally, at the experimental endpoint, stain cells with 100 nM of the membrane-permeant green fluorescent dye (see Table of Materials). Normalize data to % necroptotic cells as the ratio of green fluorescence/green fluorescence at endpoint.</li>
</ol>
3. Live-cell Confocal Microscopy Imaging of Plasma Membrane Recruitment and Permeabilization by MLKL
<ol>
	<li>Plate mlkl-/- MEFs expressing NBB140-2xFV-Venus at a density of 20,000 cells per well (0.5 mL/well) in a glass bottom 4-well microscopy chamber pretreated with 50 &#181;g/mL fibronectin&#160;in PBS at 37 &#176;C for 30 min and incubate for ~12 h (Figure 2B).</li>
	<li>Treat the cells with Dox (0.5 &#956;g/mL) for ~12 h to induce the expression of NBB140-2xFV-Venus.</li>
	<li>Induce necroptosis by incubating with fresh medium (1 mL/well) containing 25 nM Dim to induce NBB140-2xFV-Venus activation and translocation to the plasma membrane.</li>
	<li>Place the chamber on a spinning disc laser scanning confocal microscope built on an inverted stand equipped with environmental control and a 63 1.4 NA objective and begin imaging acquisition using software of choice (see Table of Materials).</li>
	<li>Initialize the software, select &#34;Focus&#34; icon and YFP filter configuration (excitation wavelength 515 nm).</li>
	<li>Locate the field of view and focal plane, and engage the focus maintenance system using the &#34;Definite Focus&#34; tab.</li>
	<li>To begin acquisition, select the &#34;Capture&#34; tab followed by assignment of filter configuration, appropriate EMCCD camera exposure time and intensification gain, and time-lapse acquisition parameters including interval and length of acquisition.</li>
	<li>Monitor cellular redistribution of the fluorescent NBB140-2xFV-Venus protein during necroptosis by acquiring images every 10 s by a EMCCD camera using a 515 nm laser (Movie 1). 
	NOTE: Photobleaching is a concern with fluorescent protein imaging. Venus is one of the more resistant fluorescent proteins to photobleaching29. If fluorescent proteins that are more susceptible to photobleaching are used, image every 30 s or longer to allow recovery of signal between imaging time points.</li>
	<li>To monitor plasma membrane association of NBB140-2xFV-Venus during necroptosis, image every 10 s the sample prepared in 3.3 by total internal reflection fluorescence (TIRF) microscopy using a microscope equipped with an automated TIRF slider and a 100X 1.4 NA objective and an EMCCD camera (Movie 2). Follow steps 3.5&#8211;3.7, but adjust the TIRF angle within the TIRF focus tab according to sample and bottom glass thickness of the microscopy chamber. 
	NOTE: Plasma membrane markers such as LCK-C-RFP may be used as controls for plasma membrane localization in TIRF analysis.</li>
	<li>Perform image processing to enhance quality by convolution with the negative normalized second derivative of a Gaussian function (Marr algorithm).</li>
</ol>
4. Electron Microscopy
<ol>
	<li>Plate mlkl-/- MEFs expressing NBB140-2xFV-Venus at a density of 5 million cells in a plasma-coated 150 mm cell culture dish and incubate for 12 h (Figure 3).</li>
	<li>Treat the cells with Doxycycline (0.5 &#956;g/mL) to induce the expression of NB1-140-2xFV-Venus for 12 h.</li>
	<li>Induce NBB140-2xFV-Venus activation and translocation to the plasma membrane with 25 nM of homodimerizer for 5 min. This time is established from the kinetics of necroptosis observed in live-cell imaging.</li>
	<li>Remove the media&#160;and fix cells using 10 mL of 2.5% glutaraldehyde, 2% paraformaldehyde in 0.1 M sodium cacodylate buffer pH 7.4 (cacodylate buffer) pre-warmed at 37 &#176;C.</li>
	<li>Collect the sample by scraping and spin the samples for 10 min at 500 x g. Discard the supernatant.</li>
	<li>Postfix the sample for 1.5 h in reduced 2% osmium tetroxide with 1.5% potassium ferrocyanide in 0.1 M sodium cacodylate buffer. Osmium tetroxide is a staining agent widely used in TEM to provide contrast. We used TEM as preliminary analysis prior to SEM of cell undergoing necroptosis.</li>
	<li>Rinse the sample 5 times in ultrapure water for 5 min each at 500&#160;x g, followed by rinses in buffer (see 4.6), water, and ethanol on an automatic processor. Discard the supernatant.</li>
	<li>For the SEM, stain the previously fixed samples with 1% uranyl acetate and lead aspartate heavy-metal stain31.</li>
	<li>Dehydrate the samples through a graded series of alcohol and propylene oxide solutions.</li>
	<li>Embed the sample in hard resin32 to obtain a resin block.</li>
	<li>Cut thick sections of 0.5 &#956;m to determine the correct area of analysis.</li>
	<li>Coat the samples with an ultra-thin film of electrically-conducting metal (Iridium).</li>
	<li>Image and analyze the samples (Figure 3). For quantification, a low-magnification image of the resin block surface with exposed cells is scanned at 5 keV using an electron microscope.</li>
	<li>Visualize cells across individual images captured by SEM or imaging software may be utilized to join multiple fields-of-view into one contiguous image30. Roughly 100 cells may be used to evaluate the fraction of cells undergoing necroptosis in this manner by generating a high-resolution montage in software of choice (see Table of Materials). 
	NOTE: Scoring necrotic morphology by SEM compares normal cell features with the progression of pre-necrotic or necrotic phenotypes. These features include plasma membrane alterations including microvilli disappearance, flattening, ruptures in cells ranging from 10 nm to 1 &#181;m in size, or loss of organelle structure across at least 30&#8211;40% of the cytosolic cell area.</li>
</ol>
5. Lipid Binding of MLKL by Nuclear Magnetic Resonance (NMR) Spectroscopy
<ol>
	<li>Prepare 15N-labeled NBB1-156 by standard protein expression and purification as previously described24.</li>
	<li>Dissolve 500 &#181;g of 1,2-distearoyl-sn-glycero-3-phosphoinositol ammonium salt (18:0 PI) and 1,2-dioleoyl-sn-glycero-3-phospho-(1&#39;-myo-inositol) ammonium salt (18:1 PI) in 500 &#181;L of ice-cold&#160;CHCl3 each for final concentrations of 1 mg/mL.</li>
	<li>Sonicate 1 mg/mL 18:0 and 18:1 PI in a sonication water bath for 1&#160;min at room temperature or up to 5 min in an ice-water mixture.</li>
	<li>Aliquot 1 mg/mL 18:0 and 18:1 PI into clean glass vials for individual NMR titration series (Figure 4). Transfer lipids in organic solvents using glass air-tight syringes.
	<ol>
		<li>Aliquot 132 &#181;L of 1 mg/mL 18:1 PI (molar mass = 880.137 g/mol) in CHCl3 for a final resuspension volume of 1,200 &#181;L at 125 &#181;M concentration. 
		NOTE: For 5 mm NMR tubes, prepare serial dilution volumes of &#62;1,000 &#181;L and final NMR sample volumes of &#62;500 &#181;L. For 3 mm NMR tubes, prepare serial dilution volumes of &#62;300 &#181;L and final NMR sample volumes of &#62;150 &#181;L.</li>
	</ol>
	</li>
	<li>Aliquot 1 mg/mL porcine brain L-&#945;-phosphatidylinositol-4,5-bisphosphate ammonium salt in 20:9:1 CHCl3/MeOH/H2O (brain PI(4,5)P2) into clean glass vials.</li>
	<li>Place vials under a gaseous stream of argon (Ar) or nitrogen (N2) with moderate flow to evaporate organic solvent without splashing against the glass vial walls. Five to thirty&#160;min is typically sufficient for volumes of 10&#8211;200 &#181;L organic solvent.</li>
	<li>Arrange glass vial(s) at bottom of a B&#252;chner or vacuum flask using large tweezers, seal with a rubber stopper, and attach plastic tubing connected to a vacuum line. Evacuate flask under mild vacuum overnight to remove residual organics.</li>
	<li>Overlay lipid film aliquots with inert gas, seal with an airtight lid, and store at -20 &#176;C for use within one month or -80 &#176;C for longer-term storage.</li>
	<li>Prepare NMR sample buffers without detergent (-Det) containing 20 mM NaxHyPO4 pH 6.8, 10% D2O and with detergent (+Det) containing 20 mM NaxHyPO4 pH 6.8, 10% D2O, 0.34 mM n-dodecyl-&#946;-D-maltopyranoside (DDM).</li>
	<li>Add +Det buffer to glass vial with lipid film to achieve desired concentration and sonicate in water bath for up to 30 min, alternating sonication for 10 min followed by visual inspection. 
	NOTE: Sonication may warm sample. Allow to cool to room temperature for 15 min before final protein sample reconstitution.</li>
	<li>Perform serial dilution of lipid-detergent micelles in +Det buffer using sonication of 1:1 mixtures for the desired concentration series. Starting at 125 &#181;M lipid concentration, three repetitions will yield 62.5 &#181;M, 31.3 &#181;M, and 15.6 &#181;M lipid in 0.34 mM DDM.</li>
	<li>Prepare control and reference NMR samples of protein and additives in -Det and +Det buffers, respectively. Add protein and additives to each dilution of lipid in +Det buffer. 
	NOTE: For 15N NBB156, protein is added to a final concentration of 40 &#181;M and supplemented with 2 mM deuterated dithiothreitol to keep Cys residues reduced.</li>
	<li>Transfer the appropriate volume of samples to 5 mm or 3 mm NMR tubes (see note in step 5.4).</li>
	<li>Manually load samples in NMR instrument or arrange in an automation platform such as the SampleCase loader.</li>
	<li>Acquire composite NMR spectra using standard pulse programs for 1H proton spectra as quality control followed by 2D 1H-15N correlation spectra either as transverse relaxation optimized spectroscopy (TROSY) or heteronuclear multiple quantum coherence (SOFAST-HMQC)33. 
	NOTE: Usage of 3 mm NMR tubes requires 64 scans for 1H-15N TROSY (~3 h) or 1H-15N SOFAST-HMQC (~90 min). Scan numbers are halved for 5 mm NMR tubes.</li>
	<li>Processed 2D NMR spectra may be added to a CARA repository34 for analysis or other software of choice to the user.</li>
	<li>Analyze software by annotating 2D NMR resonances for three well-dispersed and resolved peaks for each protein state. Record the peak amplitudes for each of the six peaks for each buffer condition containing NBB156 (Figure 5A).
	<ol>
		<li>Use CARA to prepare a batch-integration list (Click Main Menu heading &#34;Spectrum | Setup Batch List&#34;&#8230;) of all spectra collected and analyze&#160;using a single peak assignment file (Click Main Menu heading &#34;Peaks | Import Peaklist&#34;&#160;&#8230;and choose a user-defined .peaks file with 6 total peaks, 3 for each protein state, defined within).</li>
		<li>Tune the settings (&#34;Integrator | Tune Peak Model&#34; &#8230;) of X-width 0.06 ppm and Y-width 0.30 ppm (Click Main Menu heading &#34;Integrator | Tune Peak Model&#34; &#8230;) before recording the final output in two menu selections (1. Click Main Menu heading &#34;Integrator | Integrate Batch List&#34;) (2. Click Main Menu heading &#34;Peaks | Export Integration Table&#34;) (Figure 5B). 
		NOTE: The backbone amide resonances for residues M21, V53, and L105 have been assigned for the NBB156&#160;closed-brace state. The open-brace state was assigned to backbone amide resonances of residues G130 and A141 and the epsilon proton side-chain resonance of W133 using 3D NMR experiments24.</li>
	</ol>
	</li>
	<li>Normalize samples for direct comparison from different magnets or sample conditions by averaging the three open-brace amplitudes of the reference samples and calculating a normalization factor relating the two references. Calculate the scaled amplitudes for NBB156 resonances using the normalization factor and setting negative amplitudes to zero (Table 2). 
	Examples: 1) Comparing samples from different magnets: Magnet A, NBB156+DDM and Magnet B, NBB156+DDM. 2) Detergent comparison: 0.34 mM DDM and 1.7 mM DDM.</li>
	<li>Calculate for each resonance the scaled fraction of closed- or open-brace by dividing with the range of minimum to maximum amplitude of all spectra collected containing appropriate references of free NBB156 and fully open-brace NBB156 in detergent.</li>
	<li>Plot the normalized NMR amplitudes as a function of lipid concentration and compare the fraction of open-brace NBB156 in different conditions (Figure. 5C). 
	NOTE: Alternatively, analysis of the fraction of closed-brace conformation against lipid concentration can be performed to compare lipid binding to NBB156. We prefer the former analysis because it is quicker and better reports on the fraction fully-engaged by lipids.</li>
</ol>

<ol><li>Weinlich, R., Oberst, A., Beere, H. M., Green, D. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Necroptosis+in+development%2C+inflammation+and+disease%5BTitle%5D)+AND+%22Nature+Reviews+Molecular+Cell+Biology%22%5BJournal%5D)">Necroptosis in development, inflammation and disease.</a> Nature Reviews Molecular Cell Biology. 18 (2), 127-136 (2017).</li>
<li>Kaiser, W. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((RIP3+mediates+the+embryonic+lethality+of+caspase-8-deficient+mice%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">RIP3 mediates the embryonic lethality of caspase-8-deficient mice.</a> Nature. 471 (7338), 368-372 (2011).</li>
<li>Murphy, J. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+pseudokinase+MLKL+mediates+necroptosis+via+a+molecular+switch+mechanism%5BTitle%5D)+AND+%22Immunity%22%5BJournal%5D)">The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.</a> Immunity. 39 (3), 443-453 (2013).</li>
<li>Oberst, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Catalytic+activity+of+the+caspase-8-FLIP%28L%29+complex+inhibits+RIPK3-dependent+necrosis%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis.</a> Nature. 471 (7338), 363-367 (2011).</li>
<li>Zhang, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Functional+complementation+between+FADD+and+RIP1+in+embryos+and+lymphocytes%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Functional complementation between FADD and RIP1 in embryos and lymphocytes.</a> Nature. 471 (7338), 373-376 (2011).</li>
<li>He, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Receptor+interacting+protein+kinase-3+determines+cellular+necrotic+response+to+TNF-alpha%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.</a> Cell. 137 (6), 1100-1111 (2009).</li>
<li>Dondelinger, Y., Hulpiau, P., Saeys, Y., Bertrand, M. J. M., Vandenabeele, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+evolutionary+perspective+on+the+necroptotic+pathway%5BTitle%5D)+AND+%22Trends+in+Cell+Biology%22%5BJournal%5D)">An evolutionary perspective on the necroptotic pathway.</a> Trends in Cell Biology. 26 (10), 721-732 (2016).</li>
<li>Newton, K., Manning, G. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/26865533">Necroptosis and Inflammation.</a> Annual Review of Biochemistry. 85, 743-763 (2016).</li>
<li>Kaiser, W. J., Upton, J. W., Mocarski, E. S. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/23773332">Viral modulation of programmed necrosis.</a> Current Opinion in Virology. 3 (3), 296-306 (2013).</li>
<li>Newton, K., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27177019">RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.</a> Cell Death & Differentiation. 23 (9), 1565-1576 (2016).</li>
<li>Kearney, C. J., Martin, S. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+Inflammatory+Perspective+on+Necroptosis%5BTitle%5D)+AND+%22Molecular+Cell%22%5BJournal%5D)">An Inflammatory Perspective on Necroptosis.</a> Molecular Cell. 65 (6), 965-973 (2017).</li>
<li>Pasparakis, M., Vandenabeele, P. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/25592536">Necroptosis and its role in inflammation.</a> Nature. 517 (7534), 311-320 (2015).</li>
<li>Sun, L., Wang, X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+new+kind+of+cell+suicide%3A+mechanisms+and+functions+of+programmed+necrosis%5BTitle%5D)+AND+%22Trends+in+Biochemical+Sciences%22%5BJournal%5D)">A new kind of cell suicide: mechanisms and functions of programmed necrosis.</a> Trends in Biochemical Sciences. 39 (12), 587-593 (2014).</li>
<li>Grootjans, S., Vanden Berghe, T., Vandenabeele, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Initiation+and+execution+mechanisms+of+necroptosis%3A+an+overview%5BTitle%5D)+AND+%22Cell+Death+%26+Differentiation%22%5BJournal%5D)">Initiation and execution mechanisms of necroptosis: an overview.</a> Cell Death & Differentiation. 24 (7), 1184-1195 (2017).</li>
<li>Sun, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mixed+lineage+kinase+domain-like+protein+mediates+necrosis+signaling+downstream+of+RIP3+kinase%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.</a> Cell. 148 (1-2), 213-227 (2012).</li>
<li>Wang, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mixed+lineage+kinase+domain-like+protein+MLKL+causes+necrotic+membrane+disruption+upon+phosphorylation+by+RIP3%5BTitle%5D)+AND+%22Molecular+Cell%22%5BJournal%5D)">Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.</a> Molecular Cell. 54 (1), 133-146 (2014).</li>
<li>Cai, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Plasma+membrane+translocation+of+trimerized+MLKL+protein+is+required+for+TNF-induced+necroptosis%5BTitle%5D)+AND+%22Nature+Cell+Biology%22%5BJournal%5D)">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis.</a> Nature Cell Biology. 16 (1), 55-65 (2014).</li>
<li>Chen, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Translocation+of+mixed+lineage+kinase+domain-like+protein+to+plasma+membrane+leads+to+necrotic+cell+death%5BTitle%5D)+AND+%22Cell+Research%22%5BJournal%5D)">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death.</a> Cell Research. 24 (1), 105-121 (2014).</li>
<li>Dillon, C. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((RIPK1+blocks+early+postnatal+lethality+mediated+by+caspase-8+and+RIPK3%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.</a> Cell. 157 (5), 1189-1202 (2014).</li>
<li>Rickard, J. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((RIPK1+regulates+RIPK3-MLKL-driven+systemic+inflammation+and+emergency+hematopoiesis%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.</a> Cell. 157 (5), 1175-1188 (2014).</li>
<li>Kaiser, W. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Toll-like+receptor+3-mediated+necrosis+via+TRIF%2C+RIP3%2C+and+MLKL%5BTitle%5D)+AND+%22Journal+of+Biological+Chemistry%22%5BJournal%5D)">Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.</a> Journal of Biological Chemistry. 288 (43), 31268-31279 (2013).</li>
<li>Upton, J. W., Kaiser, W. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((DAI+Another+Way%3A+Necroptotic+Control+of+Viral+Infection%5BTitle%5D)+AND+%22Cell+Host+%26+Microbe%22%5BJournal%5D)">DAI Another Way: Necroptotic Control of Viral Infection.</a> Cell Host & Microbe. 21 (3), 290-293 (2017).</li>
<li>Tanzer, M. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Necroptosis+signalling+is+tuned+by+phosphorylation+of+MLKL+residues+outside+the+pseudokinase+domain+activation+loop%5BTitle%5D)+AND+%22Biochemical+Journal%22%5BJournal%5D)">Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop.</a> Biochemical Journal. 471 (2), 255-265 (2015).</li>
<li>Quarato, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Sequential+Engagement+of+Distinct+MLKL+Phosphatidylinositol-Binding+Sites+Executes+Necroptosis%5BTitle%5D)+AND+%22Molecular+Cell%22%5BJournal%5D)">Sequential Engagement of Distinct MLKL Phosphatidylinositol-Binding Sites Executes Necroptosis.</a> Molecular Cell. 61 (4), 589-601 (2016).</li>
<li>Davies, K. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+brace+helices+of+MLKL+mediate+interdomain+communication+and+oligomerisation+to+regulate+cell+death+by+necroptosis%5BTitle%5D)+AND+%22Cell+Death+%26+Differentiation%22%5BJournal%5D)">The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis.</a> Cell Death & Differentiation. , (2018).</li>
<li>Su, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+plug+release+mechanism+for+membrane+permeation+by+MLKL%5BTitle%5D)+AND+%22Structure%22%5BJournal%5D)">A plug release mechanism for membrane permeation by MLKL.</a> Structure. 22 (10), 1489-1500 (2014).</li>
<li>Dondelinger, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((MLKL+compromises+plasma+membrane+integrity+by+binding+to+phosphatidylinositol+phosphates%5BTitle%5D)+AND+%22Cell+Reports%22%5BJournal%5D)">MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates.</a> Cell Reports. 7 (4), 971-981 (2014).</li>
<li>Llambi, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((BOK+Is+a+Non-canonical+BCL-2+Family+Effector+of+Apoptosis+Regulated+by+ER-Associated+Degradation%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation.</a> Cell. 165 (2), 421-433 (2016).</li>
<li>Malkani, N., Schmid, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Some+secrets+of+fluorescent+proteins%3A+distinct+bleaching+in+various+mounting+fluids+and+photoactivation+of+cyan+fluorescent+proteins+at+YFP-excitation%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Some secrets of fluorescent proteins: distinct bleaching in various mounting fluids and photoactivation of cyan fluorescent proteins at YFP-excitation.</a> PLoS One. 6 (4), 18586(2011).</li>
<li>Perez, A. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+workflow+for+the+automatic+segmentation+of+organelles+in+electron+microscopy+image+stacks%5BTitle%5D)+AND+%22Frontiers+in+Neuroanatomy%22%5BJournal%5D)">A workflow for the automatic segmentation of organelles in electron microscopy image stacks.</a> Frontiers in Neuroanatomy. 8, 126(2014).</li>
<li>Walton, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lead+aspartate%2C+an+en+bloc+contrast+stain+particularly+useful+for+ultrastructural+enzymology%5BTitle%5D)+AND+%22Journal+of+Histochemistry+%26+Cytochemistry%22%5BJournal%5D)">Lead aspartate, an en bloc contrast stain particularly useful for ultrastructural enzymology.</a> Journal of Histochemistry & Cytochemistry. 27 (10), 1337-1342 (1979).</li>
<li>Denk, W., Horstmann, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Serial+block-face+scanning+electron+microscopy+to+reconstruct+three-dimensional+tissue+nanostructure%5BTitle%5D)+AND+%22PLoS+Biology%22%5BJournal%5D)">Serial block-face scanning electron microscopy to reconstruct three-dimensional tissue nanostructure.</a> PLoS Biology. 2 (11), 329(2004).</li>
<li>Rossi, P., Xia, Y., Khanra, N., Veglia, G., Kalodimos, C. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((15N+and+13C-+SOFAST-HMQC+editing+enhances+3D-NOESY+sensitivity+in+highly+deuterated%2C+selectively+%5B1H%2C13C%5D-labeled+proteins%5BTitle%5D)+AND+%22Journal+of+Biomolecular+NMR%22%5BJournal%5D)">15N and 13C- SOFAST-HMQC editing enhances 3D-NOESY sensitivity in highly deuterated, selectively [1H,13C]-labeled proteins.</a> Journal of Biomolecular NMR. 66 (4), 259-271 (2016).</li>
<li>Keller, R. <a target="_blank" href="http://cara.nmr-software.org/downloads/3-85600-112-3.pdf">The computer aided resonance assignment tutorial.</a> Cantina Verlag. , (2004).</li>
<li>Chen, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Diverse+sequence+determinants+control+human+and+mouse+receptor+interacting+protein+3+%28RIP3%29+and+mixed+lineage+kinase+domain-like+%28MLKL%29+interaction+in+necroptotic+signaling%5BTitle%5D)+AND+%22Journal+of+Biological+Chemistry%22%5BJournal%5D)">Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.</a> Journal of Biological Chemistry. 288 (23), 16247-16261 (2013).</li>
<li>Tanzer, M. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Evolutionary+divergence+of+the+necroptosis+effector+MLKL%5BTitle%5D)+AND+%22Cell+Death+%26+Differentiation%22%5BJournal%5D)">Evolutionary divergence of the necroptosis effector MLKL.</a> Cell Death & Differentiation. 23 (7), 1185-1197 (2016).</li>
</ol>

We provide protocols for techniques that we combined to implicated MLKL as the putative executioner of plasma membrane rupture24. In addition to deciphering the regulatory network that regulates MLKL-mediated necroptosis, these techniques can be used independently to characterize other suitable biological systems. Practically speaking, these techniques are medium- to low-throughput discovery tools.
We have routinely used live-cell imaging of NBB140-2xFV-Venus...

Identifying genetic components of necroptosis has facilitated the use of animal models to test the implication of necroptosis in physiology and disease1,2,3,4,5. Knockout of RIPK3 or MLKL in mice had minimal implication in development and adult homeostasis suggesting that necroptosis is not essential for life3,6. Moreover, certain species do not contain either RIPK3 or MLKL genes, supporting the non-essential role of necroptosis in animals7,8. On the other hand, challenging knockout animal models with various pathologies induced in the laboratory has revealed an important role of necroptosis in inflammation, innate immunity, and viral infection9,10,11,12.
Necroptosis can be activated in several ways by signaling through different innate immunity sensors, all of which result in the activation of RIPK31,13,14. Active RIPK3 in turn phosphorylates and activates MLKL3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18. The most studied, and perhaps the most complex way, leading to activation of RIPK3 involves death receptor ligation, which bifurcates based on the downstream composition of the signaling complexes to either induce apoptosis or necroptosis1. Necroptosis ensues when signaling through RIPK1 is favored and results in engagement of RIPK319,20. This outcome is easily favored upon pharmacological inhibition or genetic deletion of caspase 8, a putative endogenous inhibitor of necroptosis that keeps necroptosis at bay. RIPK1 binds to and activates RIPK3. Another way to activate necroptosis is through Toll-like receptors TLR3/TLR4 signaling, which engages and activates RIPK3 through TIR-domain-containing adapter-inducing interferon-&#946; (TRIF)21. Yet another way to die by necroptosis is by activation of the DNA sensor DAI, which directly engages and activates RIPK322.
MLKL is a cytosolic protein comprised of an N-terminal helix bundle (NB) domain and a C-terminal pseudokinase domain (psKD) linked by a regulatory brace region3. In normal cells, MLKL is found in the cytosol where it is thought to be in an inactive complex with RIPK314. Activation of necroptosis triggers RIPK3 phosphorylation of MLKL in the activation loop of the psKD, and potentially additional sites in the NB and brace3,15,23. Phosphorylation induces a conformational change in MLKL that results in dissociation from RIPK314. Poorly understood conformational changes release the brace from the psKD24. The brace, which contains 2 helices, mediates oligomerization of MLKL into a putative trimer through the C-terminal helix25. The N-terminal helix of the brace inhibits the NB domain, which is essential for membrane permeabilization24,26. In isolation, NB domain is sufficient to induce plasma membrane permeabilization and necroptosis16,24,27. The pro-necroptotic activity of NB was reconstituted in mouse embryonic fibroblasts deficient in MLKL (mlkl-/- MEFs). NB is a lipid binding domain that preferentially engages the phospholipid phosphatidylinositol 4,5 diphosphate (PIP2). We proposed a stepwise mechanism of activation of MLKL, wherein brace oligomerization facilitates recruitment of MLKL to the plasma membrane via weak interactions of NB with the PIP2 polar head group24. At the membrane, the NB undergoes regulated exposure of an additional high-affinity binding site for PIP2, which is masked by the brace in inactive MLKL. Overall, the multiple interactions of NB with PIP2 destabilize the plasma membrane leading to its rupture, although the molecular mechanism of these events have not been elucidated.
Here we illustrate specific methods used to characterize the function of MLKL as executioner of necroptosis24. In particular, we focus on the most minimal domain of MLKL, the NB and brace (NBB), which is regulated by brace inhibition and can be activated through enforced dimerization to induce plasma membrane rupture and necroptosis. We describe our inducible expression system combined with enforced drug-induced FKBP-mediated dimerization for live-cell imaging, and electron microscopy of cells undergoing necroptosis. Additionally, we illustrate our in vitro NMR analysis of the interactions of NBB with phosphatidylinositols (PIPs).

<table><tbody><tr><td>&lt;strong&gt;Cloning and cell line generation&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>pRetroX-TRE3G</td><td>Clontech</td><td>631188</td><td></td></tr><tr><td>Tet-On transactivator plasmid</td><td></td><td></td><td>Llambi &lt;em&gt;et al.&lt;/em&gt;, 2016</td></tr><tr><td>Mouse Embryonic Fibroblasts (MEFs) mlkl-/-</td><td></td><td></td><td>Dillon &lt;em&gt;et al.&lt;/em&gt;, 2014</td></tr><tr><td>Blasticidin S Hydrochloride</td><td>Thermo Fisher Scientific</td><td>BP2647100 CAS#3513-03-9</td><td></td></tr><tr><td>&lt;strong&gt;Cell death quantification and live-cell microscopy&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Doxycycline</td><td>Clontech</td><td>631311 CAS# 24390-14-5</td><td></td></tr><tr><td>B/B Homodimerizer AP20187</td><td>Takara</td><td>635059 CAS# 195514-80-8</td><td></td></tr><tr><td>SYTOX Green</td><td>Thermo Fisher Scientific</td><td>S7020</td><td></td></tr><tr><td>Syto16</td><td>Thermo Fisher Scientific</td><td>S7578</td><td></td></tr><tr><td>&lt;strong&gt;NMR&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>15 N Ammonium Chloride</td><td>Cambridge Isotope Laboratories</td><td>NLM-467-10 CAS# 12125-02-9</td><td></td></tr><tr><td>Deuterated DTT</td><td>Cambridge Isotope Laboratories</td><td>DLM-2622-1</td><td></td></tr><tr><td>Deuterium Oxide</td><td>Sigma Aldrich</td><td>617385-1 CAS# 7789-20-0</td><td></td></tr><tr><td>n-Dodecyl-&amp;beta;-D-Maltopyranoside</td><td>Anatrace</td><td>D310 CAS# 69227-93-6</td><td></td></tr><tr><td>L-&amp;alpha;-phosphatidylinositol-4,5-bisphosphate (Brain, Porcine) (ammonium salt)</td><td>Avanti Polar Lipids</td><td>840046X CAS# 383907-42-4</td><td></td></tr><tr><td>1,2-distearoyl-sn-glycero-3-phosphoinositol (ammonium salt) (18:0 PI)</td><td>Avanti Polar Lipids</td><td>850143 CAS# 849412-67-5</td><td></td></tr><tr><td>1,2-dioleoyl-sn-glycero-3-phospho-(1&#039;-myo-inositol) (ammonium salt) (18:1)</td><td>Avanti Polar Lipids</td><td>850149 CAS# 799268-53-4</td><td></td></tr><tr><td>&lt;strong&gt;Specialized Equipment&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>IncuCyte FLR or ZOOM</td><td>Essen BioScience, Inc.</td><td></td><td>Live-cell microscopy imaging</td></tr><tr><td>Helios NanoLab 660 DualBeam&amp;nbsp;</td><td>Thermo Fisher Scientific</td><td></td><td>Electron microscope</td></tr><tr><td>&lt;strong&gt;Software&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>IncuCyte 2011A Rev2 v20111.3.4288 (FLR)</td><td>Essen BioScience, Inc.</td><td>http://www.essenbioscience.com</td><td>Imaging analysis</td></tr><tr><td>FEI MAPS</td><td>Thermo Fisher Scientific</td><td>https://www.fei.com/software/maps/</td><td>EM analysis</td></tr><tr><td>TopSpin v3.2</td><td>Bruker BioSpin</td><td>http://www.bruker.com</td><td>NMR data collection</td></tr><tr><td>CARA v1.9.1.7</td><td></td><td>http://cara.nmr.ch/&amp;nbsp;</td><td>NMR data analysis</td></tr><tr><td>Slidebook</td><td>3i (Intelligent Imaging Innovations)</td><td>https://www.intelligent-imaging.com/slidebook</td><td>Confocal microscopy</td></tr></tbody></table>

characterization of mlkl-mediated plasma membrane rupture in necroptosis

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Necroptosis is a programmed cell death pathway triggered by activation of receptor interacting protein kinase 3 (RIPK3), which phosphorylates and activates the mixed lineage kinase-like domain pseudokinase, MLKL, to rupture or permeabilize the plasma membrane. Necroptosis is an inflammatory pathway associated with multiple pathologies including autoimmunity, infectious and cardiovascular diseases, stroke, neurodegeneration, and cancer. Here, we describe protocols that can be used to characterize MLKL as the executioner of plasma membrane rupture in necroptosis. We visualize the process of necroptosis in cells using live-cell imaging with conventional and confocal fluorescence&#160;microscopy, and in fixed cells using electron microscopy, which together revealed the redistribution of MLKL from the cytosol to the plasma membrane prior to induction of large holes in the plasma membrane. We present in vitro nuclear magnetic resonance (NMR) analysis using lipids to identify putative modulators of MLKL-mediated necroptosis. Based on this method, we identified quantitative lipid-binding preferences and phosphatidyl-inositol phosphates (PIPs) as critical binders of MLKL that are required for plasma membrane targeting and permeabilization in necroptosis.

Visualizing regulated necroptosis execution in live cells has been possible through inducible expression of a minimal truncated MLKL construct, NBB140-2xFV-Venus. This construct maintains the ability to induce plasma membrane permeabilization and is activated through Dim-induced oligomerization of the FKBP cassette (2xFV). We observe and quantify necroptosis by live-cell microscopy imaging, monitoring kinetically (every 5 min) the uptake of a cell impermeable green fluorescence...

We report methods for characterization of MLKL-mediated plasma membrane rupture in necroptosis including conventional and confocal live-cell microscopy imaging, scanning electron microscopy, and NMR-based lipid binding.

Necroptosis is a programmed cell death pathway triggered by activation of receptor interacting protein kinase 3 (RIPK3), which phosphorylates and ...

characterization-mlkl-mediated-plasma-membrane-rupture

Research

JoVE Journal

Biology

Here, we present a protocol for the determination of intracellular signaling events induced in viable cells by physical interaction with adjacent dead or dying cells. The protocol focuses on signaling events induced by receptor-mediated recognition of the dead cells, as opposed to their phagocytic uptake or release of soluble mediators.

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

This protocol describes a simple method for isolating and culturing primary mouse cerebral granule neurons (CGNs) from 6-7 day old pups, efficient transduction of CGNs for loss and gain of function studies, and modelling NMDA-induced neuronal excitotoxicity, low-potassium-induced cell death, DNA-damage, and oxidative stress using the same culture model.

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

We describe the detection of NLRP3 inflammasome activation on cellular basis using fluorescence microscopy and staining for active caspase-1 and the adaptor, ASC. A lactate dehydrogenase release assay is presented to detect pyroptotic lysis on a population basis. These techniques can be adapted to study many aspects of inflammasome biology.

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Here we describe a high-throughput fluorescence-based assay that measures the plasma membrane resealing efficiency through fluorometric and imaging analyses in living cells. This assay can be used for screening drugs or target genes that regulate plasma membrane resealing in mammalian cells.

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells

Tyramide signal amplification during immunofluorescent staining enables the sensitive detection of phosphorylated RIPK3 and MLKL during ZBP1-induced necroptosis after HSV-1 infection.

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

This protocol is based on LPS and ATP-induced death of PMA-differentiated THP-1 macrophages. We use flow cytometry to analyze Annexin V and 7-AAD double staining to detect cell death, using the whole cell and employing scanning electron microscopy to observe the cell membrane morphology.

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

This protocol describes a live-cell imaging method for monitoring lysosomal membrane permeabilization during necroptosis, utilizing fluorescent probes that detect changes in lysosomal membrane integrity and acidification.

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis

We describe how to measure near membrane and global intracellular calcium dynamics in cultured astrocytes using total internal reflection and epifluorescence microscopy.

Measuring Near Plasma Membrane and Global Intracellular Calcium Dynamics in Astrocytes

Regulated endocytosis governs the cell surface expression levels of the majority of membrane proteins.  Here we utilize reducible, membrane impermeant biotinylation reagents to measure the endocytic rate of the dopamine transporter (DAT), a polytopic membrane protein.  The method facilitates a straightforward approach to measuring the endocytic rate of most plasma membrane proteins.

Measuring Plasma Membrane Protein Endocytic Rates by Reversible Biotinylation

This protocol describes a rapid technique to quantify the translocation of GLUT4 from the cytoplasm to the plasma membrane of cells by flow cytometry.

Quantitative Measurement of GLUT4 Translocation to the Plasma Membrane by Flow Cytometry

Learn live-cell microscopy and NMR techniques to characterize MLKL-mediated plasma membrane rupture in necroptosis using mouse embryonic fibroblasts. These methods directly implicate MLKL as the executioner of cell death.

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Explore More Videos